Disease · EFO_0004352
Comparisons in its trials34
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 34
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| High Dose Vitamin D Formulation vs Placebo: serious adverse events | 14 of 690 | 18 of 668 | 1,358 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: deaths from any cause | 159 of 681 | 137 of 656 | 1,337 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: Hospital Mortality to Day 90 | 92 of 538 | 72 of 539 | 1,077 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: All-cause, All-location Mortality to Day 90 | 125 of 531 | 109 of 528 | 1,059 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: All-cause, All Location Mortality to Day 28 | 92 of 531 | 69 of 528 | 1,059 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: Alive and Home (Prior Level of Care) at Day 90 | 348 of 528 | 345 of 526 | 1,054 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: Hypercalcemia to Day 14 | 14 of 513 | 11 of 523 | 1,036 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: Falls to Day 90 | 36 of 507 | 27 of 507 | 1,014 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: Fall-related Fractures to Day 90 | 4 of 507 | 2 of 507 | 1,014 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: Kidney Stones to Day 90 | 0 of 507 | 3 of 507 | 1,014 | NCT03096314 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: New Renal Replacement Therapy (RRT) | 20 of 489 | 18 of 500 | 989 | NCT03096314 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: deaths from any cause | 36 of 447 | 45 of 456 | 903 | NCT02086500 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: serious adverse events | 4 of 447 | 7 of 456 | 903 | NCT02086500 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: Multiple Organ Failure | 33 of 447 | 39 of 453 | 900 | NCT02086500 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: 24 Hour Mortality | 16 of 447 | 17 of 453 | 900 | NCT02086500 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: Hyperfinbrinolysis | 145 of 447 | 144 of 453 | 900 | NCT02086500 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: Acute Lung Injury | 42 of 447 | 39 of 453 | 900 | NCT02086500 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: Nosocomial Infection | 88 of 447 | 66 of 453 | 900 | NCT02086500 | Trial comparisons |
| Prehospital Tranexamic Acid vs Control: 30 Day Mortality | 36 of 442 | 45 of 452 | 894 | NCT02086500 | Trial comparisons |
| High Dose Vitamin D Formulation vs Placebo: Number of Participants Who Developed (New) ARDS to Day 7 | 20 of 411 | 17 of 412 | 823 | NCT03096314 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/EFO_0004352/comparisons